Interesting market. I placed a small bet in the “more likely than not” direction given the importance of the CB1 receptor to cannabis consumption and tolerance, but it’s really a shot in the dark. I’m wondering how could could prove/disprove this hypothesis, and what that study would look like. I’m also only seeing a handful of clinical trials registered studying CHS, so it may be awhile before this can be resolved.

@benmanns Yeah I wouldn't be surprised if we still weren't sure what's going on with CHS in 2030. The medical industry as a whole isn't taking this very serious. It's the emergency rooms seeing most of these cases and it's hard to get a clear diagnosis. CDC doesn't even have information on it yet.